Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.
Gangaev A, van Sleen Y, Brandhorst N, Hoefakker K, Prajapati B, Singh A, Boerma A, van der Heiden M, Oosting SF, van der Veldt AAM, Hiltermann TJN, GeurtsvanKessel CH, Dingemans AC, Smit EF, de Vries EGE, Haanen JBAG, Kvistborg P, van Baarle D. Gangaev A, et al. Among authors: van baarle d. Front Immunol. 2024 Aug 27;15:1447555. doi: 10.3389/fimmu.2024.1447555. eCollection 2024. Front Immunol. 2024. PMID: 39257577 Free PMC article.
COVID-19 vaccination: the VOICE for patients with cancer.
van der Veldt AAM, Oosting SF, Dingemans AC, Fehrmann RSN, GeurtsvanKessel C, Jalving M, Rimmelzwaan GF, Kvistborg P, Blank CU, Smit EF, Lemmens VEEP, Hiltermann TJN, Koopmans MPG, Huckriede ALW, Rots NY, van Els CACM, van Baarle D, Haanen JBAG, de Vries EGE. van der Veldt AAM, et al. Among authors: van els cacm, van baarle d. Nat Med. 2021 Apr;27(4):568-569. doi: 10.1038/s41591-021-01240-w. Nat Med. 2021. PMID: 33589821 No abstract available.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Oosting SF, van der Veldt AAM, GeurtsvanKessel CH, Fehrmann RSN, van Binnendijk RS, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, Bhattacharya A, van der Heiden M, Rimmelzwaan GF, Kvistborg P, Blank CU, Koopmans MPG, Huckriede ALW, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE. Oosting SF, et al. Among authors: van binnendijk rs, van der heiden m, van els cacm, van der veldt aam, van baarle d. Lancet Oncol. 2021 Dec;22(12):1681-1691. doi: 10.1016/S1470-2045(21)00574-X. Epub 2021 Nov 9. Lancet Oncol. 2021. PMID: 34767759 Free PMC article. Clinical Trial.
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Oosting SF, van der Veldt AAM, Fehrmann RSN, GeurtsvanKessel CH, van Binnendijk RS, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, Bhattacharya A, de Wilt F, Boerma A, van Zijl L, Rimmelzwaan GF, Kvistborg P, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE. Oosting SF, et al. Among authors: van binnendijk rs, van zijl l, van els cacm, van der veldt aam, van baarle d. Lancet Oncol. 2022 Jul;23(7):833-835. doi: 10.1016/S1470-2045(22)00203-0. Epub 2022 Apr 25. Lancet Oncol. 2022. PMID: 35483383 Free PMC article. No abstract available.
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.
Sablerolles RSG, Goorhuis A, GeurtsvanKessel CH, de Vries RD, Huckriede ALW, Koopmans MPG, Lafeber M, Postma DF, van Baarle D, Visser LG, Dalm VASH, Kootstra NA, Rietdijk WJR, van der Kuy PHM. Sablerolles RSG, et al. Among authors: van baarle d, van der kuy phm. Front Immunol. 2021 Sep 24;12:753319. doi: 10.3389/fimmu.2021.753319. eCollection 2021. Front Immunol. 2021. PMID: 34691071 Free PMC article. No abstract available.
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Frölke SC, Geers D, GeurtsvanKessel CH, den Hartog G, van der Heiden M, Imhof C, Kho MML, Koopmans MPG, Malahe SRK, Mattheussens WB, van der Molen R, van Mourik D, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Gansevoort RT, Hilbrands LB, Reinders MEJ; RECOVAC Collaborators. Sanders JF, et al. Among authors: van binnendijk r, van der heiden m, van der molen r, van mourik d, van baarle d. Transplantation. 2022 Apr 1;106(4):821-834. doi: 10.1097/TP.0000000000003983. Transplantation. 2022. PMID: 34753894 Free PMC article.
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome.
Verstappen GM, de Wolff L, Arends S, Heiermann HM, van Sleen Y, Visser A, Terpstra JH, Diavatopoulos DA, van der Heiden M, Vissink A, van Baarle D, Kroese FGM, Bootsma H. Verstappen GM, et al. Among authors: van der heiden m, van sleen y, van baarle d. RMD Open. 2022 Apr;8(1):e002265. doi: 10.1136/rmdopen-2022-002265. RMD Open. 2022. PMID: 35414631 Free PMC article.
High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients.
Hoek RA, Verschuuren EA, de Vries RD, Vonk JM, van Baarle D, van der Heiden M, van Gemert JP, Gore EJ, Niesters HG, Erasmus M, Hellemons ME, Scherbeijn SM, Wijbenga N, Mahtab EAF, GeurtsvanKessel CH, Buter CVL. Hoek RA, et al. Among authors: van der heiden m, van gemert jp, van baarle d. J Heart Lung Transplant. 2022 Jun;41(6):765-772. doi: 10.1016/j.healun.2022.03.006. Epub 2022 Mar 16. J Heart Lung Transplant. 2022. PMID: 35606065 Free PMC article.
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF, Messchendorp AL, de Vries RD, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Geers D, Schmitz KS, GeurtsvanKessel CH, den Hartog G, Kho MML, Koopmans MPG, van der Molen RG, Remmerswaal EBM, Rots N, Gansevoort RT, Bemelman FJ, Hilbrands LB, Reinders MEJ; VACcination Immune Response Study (RECOVAC) Collaborators. Sanders JF, et al. Among authors: van binnendijk r, van der molen rg, van baarle d. Clin Infect Dis. 2023 Feb 8;76(3):e188-e199. doi: 10.1093/cid/ciac557. Clin Infect Dis. 2023. PMID: 35796536 Free PMC article. Clinical Trial.
233 results